1. Home
  2. IBRX vs MSGE Comparison

IBRX vs MSGE Comparison

Compare IBRX & MSGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$2.38

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Madison Square Garden Entertainment Corp.

MSGE

Madison Square Garden Entertainment Corp.

HOLD

Current Price

$54.65

Market Cap

2.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
MSGE
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IBRX
MSGE
Price
$2.38
$54.65
Analyst Decision
Strong Buy
Buy
Analyst Count
7
6
Target Price
$9.71
$53.67
AVG Volume (30 Days)
11.5M
327.8K
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
$82,555,000.00
$962,282,000.00
Revenue This Year
$667.18
$9.36
Revenue Next Year
$88.32
$5.33
P/E Ratio
N/A
$75.84
Revenue Growth
1025.95
0.68
52 Week Low
$1.83
$28.29
52 Week High
$4.27
$55.75

Technical Indicators

Market Signals
Indicator
IBRX
MSGE
Relative Strength Index (RSI) 56.50 74.63
Support Level $2.17 $48.66
Resistance Level $2.40 $55.75
Average True Range (ATR) 0.15 1.46
MACD 0.03 0.43
Stochastic Oscillator 72.22 87.33

Price Performance

Historical Comparison
IBRX
MSGE

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About MSGE Madison Square Garden Entertainment Corp.

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Share on Social Networks: